1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Thailand Pharmaceuticals and Healthcare Report Q2 2016

Thailand Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 103 pages

Includes 3 FREE quarterly updates

Headline Expenditure Projections

- Pharmaceuticals: THB152bnbn (USD4.4bn) in 2015 to THB160bn (USD4.5bn) in 2016; +5.3% in localcurrency terms and +1.9% in US dollar terms.

- Healthcare: THB614bn (USD17.9bn) in 2015 to THB655bn (USD18.5bn) in 2016: +6.7% in localcurrency and +-3.3% in US dollar terms.

Table Of Contents

Thailand Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Thailand 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Thailand 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Thailand 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Thailand 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Thailand 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Thailand 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Thailand 2014-2020) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Thailand 2014-2020) 32
Industry Risk/Reward Index 33
Asia Pacific Risk/Reward Index 33
Thailand Risk/Reward Index 39
Rewards 39
Risks 39
Regulatory Review 41
Intellectual Property Issues 44
Pricing Regime 45
Table: Price Build-Up Of Medicines In Thailand 46
Reimbursement Regime 46
Market Overview 48
Healthcare Sector 48
Table: Major Health Insurance Programmes In Thailand 50
Table: Healthcare Resources (Thailand 2010-2015) 51
Table: Healthcare Personnel (Thailand 2010-2015) 52
Table: Healthcare Activity (Thailand 2010-2015) 52
Research and Development 52
Clinical Trials 54
Epidemiology 55
Table: Estimated Number Of New Cases Of Cancer In Thailand 59
Competitive Landscape 60
Research-Based Industry 60
Table: PReMA Members 60
Table: Multinational Market Activity 61
Generic Drugmakers 62
Table: Pharmaceutical Manufacturers Of Modern Drugs, 2007-2012 63
Pharmaceutical Distribution 63
Pharmaceutical Retail Sector 64
Company Profile 67
Berlin Pharmaceutical Industry 67
Biolab 70
GlaxoSmithKline 72
Government Pharmaceutical Organisation 75
Merck and Co 79
Novartis 82
Pfizer 85
Sanofi 89
Demographic Forecast 92
Table: Population Headline Indicators (Thailand 1990-2025) 93
Table: Key Population Ratios (Thailand 1990-2025) 93
Table: Urban/Rural Population and Life Expectancy (Thailand 1990-2025) 94
Table: Population By Age Group (Thailand 1990-2025) 94
Table: Population By Age Group % (Thailand 1990-2025) 95
Glossary 97
Methodology 99
Pharmaceutical Expenditure Forecast Model 99
Healthcare Expenditure Forecast Model 99
Notes On Methodology 100
Risk/Reward Index Methodology 101
Index Overview 102
Table: Pharmaceutical Risk/Reward Index Indicators 102
Indicator Weightings 103

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.